Newsroom
June 23, 2025
PipelineReview.com: Cirius Therapeutics Announces Positive Data for MPC Inhibitor 0602K Alone and in Combination with Tirzepatide
June 23, 2025
FirstWord Pharma: Cirius Therapeutics Announces Positive Data for MPC Inhibitor 0602K Alone and in Combination with Tirzepatide
June 9, 2025
Yajaira Johnson-Esparza, PhD, licensed clinical psychologist and clinical associate professor, Department of Family and Community Medicine, was interviewed for this news segment. Watch Now: KVDA-TV: Cómo afecta la diabetes y el bienestar emocional, según experta – Telemundo San Antonio (60) Watch Now: KVDA-TV YouTube: La conexión entre la diabetes y el bienestar emocional. | […]
May 1, 2025
SGLT2i-drug induced hyperketonemia improved cardiac function for Type 2 diabetic patients with heart failure Heart disease is the leading cause of death for people with Type 2 diabetes and people with diabetes are more than twice as likely to experience a heart attack or stroke, according to the American Diabetes Association. While most cardiologists focus […]
April 4, 2025
This story is featured in the April 2025 Bexar County Medical Society’s San Antonio Medicine magazine About one in 10 Texans is living with Type 2 diabetes — one of the highest rates of the disease in the United States. In San Antonio, the rate is one in six people and another third of the […]
March 5, 2025
UT Health San Antonio was mentioned in this news segment. Read More